Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data o...
Advanced Insights from Sionna Therapeutics: Promising Phase 1 Data Revealed at the 2025 North American Cystic Fibrosis ConferenceAt the recent 2025 North American Cystic Fibrosis Conference, Sionna Therapeutics made sig...
Oct 24, 2025
• Major Pharmaceutical Preparations Industry
Clinical Study
Sionna Therapeutics Inc
